New Wave Wealth Advisors LLC Biomarin Pharmaceutical Inc Transaction History
New Wave Wealth Advisors LLC
- $235 Billion
- Q2 2025
A detailed history of New Wave Wealth Advisors LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, New Wave Wealth Advisors LLC holds 11,622 shares of BMRN stock, worth $675,703. This represents 0.27% of its overall portfolio holdings.
Number of Shares
11,622
Previous 4,330
168.41%
Holding current value
$675,703
Previous $306 Million
108.72%
% of portfolio
0.27%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
185MCall Options Held
1.25MPut Options Held
992K-
Black Rock Inc. New York, NY22.7MShares$1.32 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.1 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.03 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$869 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$628 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...